文献速递生殖医学

卵母细胞滑面内质网聚集与刺激方案及ICSI/IVF结局的关系

Occurrence of smooth endoplasmic reticulum aggregates in metaphase II oocytes: relationship with stimulation protocols and outcome of ICSI and IVF cycles.
PubMed 文献 · Hum Reprod · 2021-01-01

该回顾性队列研究纳入2012-2019年1129名女性的1662个IVF/ICSI周期,发现2.8%的MII卵母细胞存在滑面内质网聚集(SERa)。SERa+周期刺激时间更长、触发日孕酮更高、卵泡更大,受精率显著降低,临床成功率较低,但未观察到新生儿出生体重或畸形差异。

要点

  • SERa+周期刺激时间、触发日孕酮、卵泡大小及获卵数均显著高于SERa-周期。
  • SERa+周期及卵母细胞的受精率显著降低,囊胚形成率有降低趋势(P=0.059)。
  • 卵巢刺激持续时间是SERa+卵母细胞出现的预测因素,提示触发时机的重要性。

核心结论

  • 次优的延长卵巢刺激可能通过诱导SERa发生而损害卵母细胞,降低其生殖潜能。

研究设计与样本

  • 回顾性纵向队列研究,纳入2012-2019年1129名20-44岁女性的1662个IVF/ICSI周期(180个SERa+周期,1482个SERa-周期)。

主要发现

  • SERa+周期刺激时间(P=0.002)、触发日血清孕酮(P=0.004)、卵泡大小(P=0.046)、获卵数(P=0.004)及MII卵母细胞数(P=0.0001)显著高于SERa-周期。
  • SERa+周期及卵母细胞的受精率显著降低(P<0.0001)。
  • SERa+周期胚胎的囊胚形成率低于SERa-周期(P=0.059)。
  • 广义估计方程模型显示卵巢刺激持续时间可预测SERa+卵母细胞的出现。

关键数值与推荐

  • SERa+周期定义为卵母细胞队列中至少一个SERa+卵母细胞;SERa-周期为形态学未受累的卵母细胞。
  • 仅进行了12次涉及至少一个SERa+胚胎的移植,无SERa+胚胎移植获得持续临床妊娠。
  • SERa+周期的临床成功率低于SERa-周期,但同一周期未受累卵母细胞所生新生儿的出生体重或畸形无差异。

临床怎么用

  • 关注卵巢刺激持续时间,避免次优的延长刺激,以降低SERa发生风险。
  • 重视触发时机的正确把握,以最大化获卵数及卵母细胞生殖潜能。
  • SERa+卵母细胞通常被丢弃,涉及SERa+胚胎的移植应谨慎。

局限性

  • SERa+卵母细胞多年被丢弃且通常避免移植SERa+胚胎,SERa+周期的临床结局主要反映未受累卵母细胞来源胚胎的移植。
  • 缺乏SERa+胚胎来源的新生儿数据,因无SERa+胚胎移植获得持续临床妊娠。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is there any association between the appearance of smooth endoplasmic reticulum aggregates (SERa) in oocytes and ovarian stimulation, embryological, clinical and neonatal outcomes of ICSI and IVF cycles? SUMMARY ANSWER: A suboptimal prolonged ovarian stimulation is detrimental to oocytes by inducing the occurrence of SERa, which reduces the reproductive potential of oocytes. WHAT IS KNOWN ALREADY: Controlled ovarian stimulation recruits oocytes of different qualities. Based on current evidence, it was agreed that non-homogeneous cytoplasm may represent the normal variability among oocytes rather than a dysmorphism with developmental significance. The only exception is the appearance of SERa within the ooplasm. Owing to the lack of univocal evidence in this literature about the safety of injecting oocytes with SERa and the mechanism responsible for the occurrence of SERa, this topic is still a matter of debate. STUDY DESIGN, SIZE, DURATION: A retrospective, longitudinal cohort study performed at a tertiary level public infertility center. We included 1662 cycles (180 SERa+ and 1482 SERa-) from 1129 women (age: 20-44 years) who underwent IVF/ICSI treatments in 2012-2019. The SERa+ cycles had at least one SERa+ oocyte in the oocyte cohort. The SERa- cycles had morphologically unaffected oocytes. PARTICIPANTS/MATERIALS, SETTING, METHODS: We collected stimulation data and embryological, clinical, neonatal outcomes of SERa- and SERa+ cycles and oocytes. MAIN RESULTS AND THE ROLE OF CHANCE: Overall, 347 out of 12 436 metaphase II oocytes (2.8%) were affected by SER. We performed only 12 transfers involving at least one SERa+ embryo. Stimulation length (P = 0.002), serum progesterone (P = 0.004) and follicle size (P = 0.046) at trigger, number of retrieved (P = 0.004) and metaphase II (P = 0.0001) oocytes were significantly higher in SERa+ than SERa- cycles. Fertilization rate was significantly (P < 0.0001) reduced in SERa+ cycles and oocytes compared to SERa- counterparts. Embryos of SERa+ cycles had a lower blastocyst formation rate compared to embryos of SERa- cycles (P = 0.059). Statistical analysis according to a generalized estimating equation model performed at patient level demonstrated that the duration of ovarian stimulation was predictive of SERa+ oocytes appearance. The clinical success of SERa+ cycles was lower than SERa- cycles, although no differences in neonatal birthweights or malformations were recorded in sibling unaffected oocytes of SERa+ cycles. LIMITATIONS, REASONS FOR CAUTION: Given that SERa+ oocytes were discarded in our center for years and transfers of embryos originating from affected oocytes were generally avoided, clinical outcomes of SERa+ cycles are largely attributable to the transfer of embryos derived from unaffected oocytes of SERa+ cycles and we did not have data about newborns from affected oocytes, since none of the transfers involving SERa+ embryos resulted in a progressive clinical pregnancy. WIDER IMPLICATIONS OF THE FINDINGS: For the first time, we speculate that the late-follicular phase elevated serum progesterone caused by a suboptimal prolonged ovarian stimulation may be detrimental to the oocytes by inducing the occurrence of SERa, resulting in negative effects on their reproductive potential. This raises the question of whether some stimulation regimens could be worse than others and a change in stimulation protocol would reduce the possibility of producing oocytes with suboptimal maturation. In particular, our data highlight the importance of correct timing of the trigger in order to maximize oocyte collection, not only in terms of numerosity but also their reproductive potential. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Massarotti C, Stigliani S, Ramone A, et al. Occurrence of smooth endoplasmic reticulum aggregates in metaphase II oocytes: relationship with stimulation protocols and outcome of ICSI and IVF cycles. Hum Reprod. 2021. PMID: 33527992. doi:10.1093/humrep/deaa376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。